-Down to Earth     Rural development minister shares concerns of activists at launch of Lancet series; stresses community role in fight against malnutrition India needs to be careful when it comes to agriculture-based nutrition as it opens the door for advocacy for transgenic food, said Jairam Ramesh, Union rural development minister, at the launch of the Lancet Series on Maternal and Child Nutrition. Ramesh was the chief guest at the programme on June...

-The Business Standard Bihar's model of health care through mobile phones is finding many takers Many things may be going wrong in India, but the one thing that has gone right is the reach of the mobile phone. It has bridged the divide between the rural and the urban areas, the rich and the poor. Governments, non-governmental organisations (NGOs) and phone companies are realising the potential of the mobile phone as a tool...

-The Business Standard Drugs are unaffordable, but price control is the wrong answer There is little doubt that medicines in India are too expensive for most of the population. For the poorest 20 per cent of Indians, the expenditure on medicines alone is 85 per cent of what they spend on their health, according to the National Sample Survey. A World Bank study on the subject found that just out-of-pocket medical costs...

-The Hindu     Restrictions on cross-media ownership in offing too The Telecom Regulatory Authority of India (TRAI) is all set to recommend the creation of an ‘institutional buffer between corporate owners and newspaper management' to the government. TRAI, which is also the regulator for the broadcasting industry, will also suggest ways to restrict cross-media ownership in line with practices in ‘most other established democracies.' TRAI chairman Rahul Khullar told The Hindu his recommendations would...

-Reuters BRUSSELS: Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant medicine to the market. The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. The EU action came two days...